Gubra A/S
CSE:GUBRA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Dell Technologies Inc
NYSE:DELL
|
Technology
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Abercrombie & Fitch Co
NYSE:ANF
|
Retail
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
S&P Global Inc
NYSE:SPGI
|
Financial Services
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Citigroup Inc
NYSE:C
|
Banking
|
| IE |
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Pharmaceuticals
|
| US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
Life Sciences Tools & Services
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
114
726
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Dell Technologies Inc
NYSE:DELL
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Abercrombie & Fitch Co
NYSE:ANF
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
S&P Global Inc
NYSE:SPGI
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Citigroup Inc
NYSE:C
|
US |
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
IE |
|
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
This alert will be permanently deleted.
Gubra A/S
Total Equity
Gubra A/S
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gubra A/S
CSE:GUBRA
|
Total Equity
kr479.7m
|
CAGR 3-Years
82%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chemometec A/S
CSE:CHEMM
|
Total Equity
kr565.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Gubra A/S
Glance View
Gubra ApS operates as biotechnology company. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.
See Also
What is Gubra A/S's Total Equity?
Total Equity
479.7m
DKK
Based on the financial report for Dec 31, 2023, Gubra A/S's Total Equity amounts to 479.7m DKK.
What is Gubra A/S's Total Equity growth rate?
Total Equity CAGR 3Y
82%
Over the last year, the Total Equity growth was 343%. The average annual Total Equity growth rates for Gubra A/S have been 82% over the past three years .
You don't have any saved screeners yet
